FDA Fast-Tracks Personalized CRISPR for Rare Diseases

A new FDA pathway could cut the time to get personalized CRISPR treatments from four years to just three months, making life-saving gene editing accessible to thousands of children born with rare genetic diseases.

Baby KJ Muldoon became the first person to receive this revolutionary treatment in February 2025.